*Национальная*

via forma full 5 https://ift.tt/sYJaIpb Manage Unsubscribe from these notifications or sign in to manage your Email service.IFTTT Manage on IFTTT: https://ifttt.com/myrecipes/personal/114580525
[Read more...](https://analogindex.livejournal.com/3600775.html)

Национальная

via forma full 5 https://ift.tt/sYJaIpb Manage Unsubscribe from these notifications or sign in to manage your Email service.IFTTT Manage on IFTTT: https://ifttt.com/myrecipes/personal/114580525
Read more...

*На iPhone вышло приложение Arc Search — браузер, поисковик и нейросеть в одном*

От создателей Arc Browser.
[Read more...](https://lifehacker.ru/arc-search-vyshel-na-ios/)

*Почему можно выгореть даже на любимой работе и как этого избежать*

Постарайтесь найти новые увлечения и не бойтесь проявлять сильные эмоции.
[Read more...](https://lifehacker.ru/kak-ne-vygoret-na-rabote/)

*8 советов, как преодолеть одиночество в отношениях*

Что делать, если романтика закончилась и любимый человек стал чужим и далёким.
[Read more...](https://burninghut.ru/odinochestvo-v-otnosheniyax/?utm_source=lifehacker.ru&utm_medium=referral&utm_campaign=teaser&utm_content=odinochestvo-v-otnosheniyax)

*Как правильно*

via forma full 5 https://ift.tt/KyW09wD Manage Unsubscribe from these notifications or sign in to manage your Email service.IFTTT Manage on IFTTT: https://ifttt.com/myrecipes/personal/114580525
[Read more...](https://analogindex.livejournal.com/3598045.html)

Как правильно

via forma full 5 https://ift.tt/KyW09wD Manage Unsubscribe from these notifications or sign in to manage your Email service.IFTTT Manage on IFTTT: https://ifttt.com/myrecipes/personal/114580525
Read more...

*Национальная*

via forma full 5 https://ift.tt/sYJaIpb Manage Unsubscribe from these notifications or sign in to manage your Email service.IFTTT Manage on IFTTT: https://ifttt.com/myrecipes/personal/114580525
[Read more...](https://analogindex.livejournal.com/3600775.html)

Национальная

via forma full 5 https://ift.tt/sYJaIpb Manage Unsubscribe from these notifications or sign in to manage your Email service.IFTTT Manage on IFTTT: https://ifttt.com/myrecipes/personal/114580525
Read more...

*Исследование: закрытие крышки унитаза при смывании не мешает распространению вирусов*

Поможет только тщательная уборка.
[Read more...](https://lifehacker.ru/zakrytaya-kryshka-unitaza-ne-meshaet-virusam/)

*Названы самые популярные сериалы на американских стримингах в 2023 году*

Рейтинг может вас удивить.
[Read more...](https://lifehacker.ru/samye-populyarnye-serialy/)

*Pfizer surprises with Q4 profit as primary-care sales offset covid slump*

Updated at 7:54 AM EST Pfizer (PFE) - Get Free Report posted a surprise fourth-quarter profit Tuesday, while sticking to its 2024 earnings forecasts, as better-than-expected sales from its primary-care division offset the ongoing slide in covid-related revenue. Pfizer said adjusted earnings for the three months ended in December were 10 cents a share, down from a profit of $1.14 over the same period a year earlier but well inside the Wall Street consensus forecast of a loss of 22 cents a share. Group revenue, Pfizer said, fell 41.4% to $14.25 billion, narrowly missing analysts' estimates of a $14.4 billion tally, thanks to what the company called an "expected decline in Comirnaty and Paxlovid" sales, referencing its Covid antiviral treatment and vaccine.Related: Humana plunge intensifies on medical-cost warning Slumping vaccine sales, which pushed overall revenue past $100 billion in 2022, forced the drugmaker to lower its 2023 profit projections in October. Pfizer told investors at the time that it would write off around $4.6 billion in inventories of Paxlovid, its oral covid treatment, and booked a further $5.5 billion noncash charge against its third-quarter earnings. Pfizer also affirmed its 2024 profit guidance, with a range of between $2.05 to $2.25 per share that includes a 40-cent hit from its $43 billion acquisition of cancer-drug specialist Seagen. Group revenue, Pfizer said, should range between $58.5 billion and $61.5 billion. “We are encouraged by the strong performance of our non-covid products in the fourth quarter of 2023, including significant contributions from new launches and robust year-over-year growth for several key in-line brands," said CEO Albert Bourla. In a statement on Jan. 30, 2024, Pfizer CEO Albert Bourla touted the health-care giant's non-covid product sales. Steven Ferdman/Getty Images "We are entering 2024 with a solid foundation," he added. "We believe our commitment to execution, maximizing the performance of our new products, and delivering the next wave of pipeline innovation will fuel Pfizer’s growth and make a difference in the lives of patients everywhere.” Pfizer shares were marked 0.4% higher in premarket trading immediately following the earnings release to indicate an opening bell price of $27.758 each. Last month, Pfizer said it would not advance a study of a two-dose obesity treatment, danuglipron, following a high level of side effects in patients involved in the Phase II trial. The decision marked a significant setback in Pfizer's ambitions to enter the weight-loss-drug market, which is currently dominated by Novo Nordisk's Wegovy. Pfizer rival Eli Lilly (LLY) - Get Free Report also won approval for its own weight-loss treatment, Zepbound, from the Food and Drug Administration in November.Related: Veteran fund manager picks favorite stocks for 2024
[Read more...](https://www.thestreet.com/investing/stocks/pfizer-surprises-with-q4-profit-as-primary-care-sales-offset-covid-slump)

Pfizer surprises with Q4 profit as primary-care sales offset covid slump

Updated at 7:54 AM EST Pfizer (PFE) - Get Free Report posted a surprise fourth-quarter profit Tuesday, while sticking to its 2024 earnings forecasts, as better-than-expected sales from its primary-care division offset the ongoing slide in covid-related revenue. Pfizer said adjusted earnings for the three months ended in December were 10 cents a share, down from a profit of $1.14 over the same period a year earlier but well inside the Wall Street consensus forecast of a loss of 22 cents a share. Group revenue, Pfizer said, fell 41.4% to $14.25 billion, narrowly missing analysts' estimates of a $14.4 billion tally, thanks to what the company called an "expected decline in Comirnaty and Paxlovid" sales, referencing its Covid antiviral treatment and vaccine.Related: Humana plunge intensifies on medical-cost warning Slumping vaccine sales, which pushed overall revenue past $100 billion in 2022, forced the drugmaker to lower its 2023 profit projections in October. Pfizer told investors at the time that it would write off around $4.6 billion in inventories of Paxlovid, its oral covid treatment, and booked a further $5.5 billion noncash charge against its third-quarter earnings. Pfizer also affirmed its 2024 profit guidance, with a range of between $2.05 to $2.25 per share that includes a 40-cent hit from its $43 billion acquisition of cancer-drug specialist Seagen. Group revenue, Pfizer said, should range between $58.5 billion and $61.5 billion. “We are encouraged by the strong performance of our non-covid products in the fourth quarter of 2023, including significant contributions from new launches and robust year-over-year growth for several key in-line brands," said CEO Albert Bourla. In a statement on Jan. 30, 2024, Pfizer CEO Albert Bourla touted the health-care giant's non-covid product sales. Steven Ferdman/Getty Images "We are entering 2024 with a solid foundation," he added. "We believe our commitment to execution, maximizing the performance of our new products, and delivering the next wave of pipeline innovation will fuel Pfizer’s growth and make a difference in the lives of patients everywhere.” Pfizer shares were marked 0.4% higher in premarket trading immediately following the earnings release to indicate an opening bell price of $27.758 each. Last month, Pfizer said it would not advance a study of a two-dose obesity treatment, danuglipron, following a high level of side effects in patients involved in the Phase II trial. The decision marked a significant setback in Pfizer's ambitions to enter the weight-loss-drug market, which is currently dominated by Novo Nordisk's Wegovy. Pfizer rival Eli Lilly (LLY) - Get Free Report also won approval for its own weight-loss treatment, Zepbound, from the Food and Drug Administration in November.Related: Veteran fund manager picks favorite stocks for 2024
Read more...

*Whoever came up with this design is very clever.*

submitted by /u/Several-Position2154 to r/interestingasfuck [link] [comments]
[Read more...](https://www.reddit.com/r/interestingasfuck/comments/1aedovp/whoever_came_up_with_this_design_is_very_clever/)

Whoever came up with this design is very clever.

submitted by /u/Several-Position2154 to r/interestingasfuck link comments
Read more...

*3 sectors dominate the U.S. jobs market - Here's who's hiring*

The December jobs report showed employers hiring at a faster pace than Wall Street anticipated. But which industries are hiring, seeing the biggest number of hires? ZipRecruiter Chief Economist Julia Pollak sat down with TheStreet’s J.D. Durkin to discuss how just three sectors were responsible for 92 percent of the hires over the past six months.Full Video Transcript Below: J.D. DURKIN: Are there any specific industries or sectors in the U.S. economy experiencing notable hiring or notable job growth right now that you're seeing? JULIA POLLAK: Well, over the past six months, just three major sectors have been responsible for 92% of all the jobs added in the U.S. economy. Those are health care, the government, and leisure and hospitality. Healthcare is just steady and stable. It's pretty recession proof and it is the sector expected to add the most jobs of the next 10 years due to demographic change and aging population and increased need and demand for health care services. The government is playing catch up. Public sector hiring took much, much, much longer to recover from the pandemic than private sector hiring, partly because the public sector is just slower when it comes to raising wages and adjusting. We are seeing that adjustment now. And so finally, as the private sector pulls back and cools down, the public sector is becoming more competitive and is having an easier time recruiting and retaining workers. The leisure and hospitality Americans like going out to restaurants and traveling. J.D. DURKIN: Hey, listen, we love the experience economy. We have seen time and time again the U.S. consumer is willing to spend on those things, whatever concert or a trip to Europe or whatever it is that we want. I wonder what else are you seeing in the data at ZipRecruiter in terms of job openings, any trends or anything you've seen that might even be a bit of a surprise, I wonder? JULIA POLLAK: Yeah, we're actually seeing a little bit of an uptick in tech job openings, and I think that's very encouraging. After a year, which could quite accurately be described as a tech-session in which the whole information sector shed jobs and was very, very slow to hire. So that does appear to be changing now. And partly that's because the stock market has had a pretty good year in 2023.
[Read more...](https://www.thestreet.com/video/heres-which-sectors-are-hiring-in-the-u-s)

3 sectors dominate the U.S. jobs market - Here's who's hiring

The December jobs report showed employers hiring at a faster pace than Wall Street anticipated. But which industries are hiring, seeing the biggest number of hires? ZipRecruiter Chief Economist Julia Pollak sat down with TheStreet’s J.D. Durkin to discuss how just three sectors were responsible for 92 percent of the hires over the past six months.Full Video Transcript Below: J.D. DURKIN: Are there any specific industries or sectors in the U.S. economy experiencing notable hiring or notable job growth right now that you're seeing? JULIA POLLAK: Well, over the past six months, just three major sectors have been responsible for 92% of all the jobs added in the U.S. economy. Those are health care, the government, and leisure and hospitality. Healthcare is just steady and stable. It's pretty recession proof and it is the sector expected to add the most jobs of the next 10 years due to demographic change and aging population and increased need and demand for health care services. The government is playing catch up. Public sector hiring took much, much, much longer to recover from the pandemic than private sector hiring, partly because the public sector is just slower when it comes to raising wages and adjusting. We are seeing that adjustment now. And so finally, as the private sector pulls back and cools down, the public sector is becoming more competitive and is having an easier time recruiting and retaining workers. The leisure and hospitality Americans like going out to restaurants and traveling. J.D. DURKIN: Hey, listen, we love the experience economy. We have seen time and time again the U.S. consumer is willing to spend on those things, whatever concert or a trip to Europe or whatever it is that we want. I wonder what else are you seeing in the data at ZipRecruiter in terms of job openings, any trends or anything you've seen that might even be a bit of a surprise, I wonder? JULIA POLLAK: Yeah, we're actually seeing a little bit of an uptick in tech job openings, and I think that's very encouraging. After a year, which could quite accurately be described as a tech-session in which the whole information sector shed jobs and was very, very slow to hire. So that does appear to be changing now. And partly that's because the stock market has had a pretty good year in 2023.
Read more...

*Форма Гражданских*

via forma full 5 https://ift.tt/7B31h2V Manage Unsubscribe from these notifications or sign in to manage your Email service.IFTTT Manage on IFTTT: https://ifttt.com/myrecipes/personal/114580525
[Read more...](https://analogindex.livejournal.com/3601203.html)

Форма Гражданских

via forma full 5 https://ift.tt/7B31h2V Manage Unsubscribe from these notifications or sign in to manage your Email service.IFTTT Manage on IFTTT: https://ifttt.com/myrecipes/personal/114580525
Read more...

*UPS slumps as mutedUPS slumps on muted 2024 sales outlook; plans big job cuts2024 sales outlook offsets mixed Q4 earnings*

Updated at 8:51 AM EST United Parcel Service (UPS) - Get Free Report posted modestly better-than-expected fourth-quarter earnings Tuesday, but weaker overall revenue and a muted outlook sent the package-delivery stalwart's shares sharply lower in early trading. The world's biggest package delivery group also said it would likely cut 12,000 jobs from its 500,000- strong workforce this year as it looks to reduce overall costs by around $1 billion. UPS said adjusted earnings for the three months ended in December were pegged at $2.47 a share, down 32% from the same period in 2022 but just ahead of the Wall Street consensus forecast of $2.46 a share. Group revenues, the company said, fell 8% to $24.9 billion, just shy of analysts' estimates of a $25.45 billion tally.Related: Analysis: Economic soft landing? How about no landing at all Domestic-segment revenue fell 7.3% to $16.92 billion, although revenue per piece, a key industry metric, rose 0.5% to $13.11. International revenue, meanwhile, were down 7% to $4.61 billion while supply-chain-solutions sales fell 11.4% to $3.4 billion. For the coming year, UPS sees revenue in the region of $91.3 billion to $92.3 billion, a 3.9% increase from the 2023 total of $90.96 billion but shy of the LSEG forecast of around $95.6 billion. “I want to thank UPSers for providing the best on-time performance of any carrier for the sixth year in a row,” said CEO Carol Tomé. Last year "was a unique and difficult year and through it all we remained focused on controlling what we could control, stayed on strategy and strengthened our foundation for future growth.” UPS shares were marked 5.7% lower in pre-market trading immediately following the earnings release to indicate an opening bell price of $149.00 each. A United Parcel Service truck searches for a house while driving along the coast of Cape Cod on July 24, 2023, in Orleans, Mass. UPS on Jan. 30, 2024, issued a muted sales outlook for the year. Robert Nickelsberg/Getty Images UPS ended its labor dispute with the Teamsters in late August after the union voted to to ratify a new five-year $30 billion contract with the world's biggest package-delivery group. Under terms of the new agreement part-time workers will earn $21 an hour, a 35.5% increase from prior levels, while certain drivers will earn as much as $49 an hour, with maximum wages of $175,000 a year, by the end of the five-year term. “This contract will improve the lives of hundreds of thousands of workers,” Teamsters President Sean O’Brien said in a statement. “Teamsters have set a new standard and raised the bar for pay, benefits, and working conditions in the package-delivery industry.”Related: Veteran fund manager picks favorite stocks for 2024
[Read more...](https://www.thestreet.com/investing/ups-slumps-as-muted-2024-sales-outlook-offsets-mixed-q4-earnings)